Validation of a Plasmodium falciparum parasite transformed with green fluorescent protein for antimalarial drug screening

J Microbiol Methods. 2007 Jun;69(3):518-22. doi: 10.1016/j.mimet.2007.03.001. Epub 2007 Mar 15.

Abstract

Aiming to replace the radioisotopic assay, the widely used procedure for vitro antimalarial drug screening, we set up a protocol using a Plasmodium falciparum strain transformed with the green fluorescent protein (PfGFP), which can be quickly and specifically quantified by flow cytometry. On the basis of a side-by-side comparison, this PfGFP-based method showed results similar to those obtained with the standard radioisotopic method.

Publication types

  • Comparative Study
  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antimalarials / pharmacology*
  • Drug Evaluation, Preclinical
  • Erythrocytes / parasitology
  • Flow Cytometry / methods*
  • Green Fluorescent Proteins / genetics*
  • Green Fluorescent Proteins / metabolism
  • Humans
  • Hypoxanthine / metabolism
  • Parasitic Sensitivity Tests / methods
  • Plasmodium falciparum / drug effects*
  • Plasmodium falciparum / genetics
  • Plasmodium falciparum / growth & development
  • Plasmodium falciparum / metabolism
  • Transfection
  • Transformation, Genetic*
  • Tritium / metabolism

Substances

  • Antimalarials
  • Tritium
  • Green Fluorescent Proteins
  • Hypoxanthine